Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Puration Inc (OP: PURA )

0.0151 USD -0.0003 (-1.95%)
Streaming Delayed Price Updated: 3:33 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,498,163
Open 0.0155
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0154
Today's Range 0.0140 - 0.0163
52wk Range 0.0070 - 0.0475
Shares Outstanding 50,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Tags ECommerce RespRx OTC
From OTC
PURA and ALKM Announce New CBD Infused Creations - Pets, Confections and Sexual Wellness
Puration, Inc. (USOTC: PURA) and Alkame Holdings Inc. (USOTC: ALKM) today announced the two companies plan to produce and test market a CBD infused liquid sugar, a CBD infused pet food supplement and a... 
From PR Newswire

Performance

YTD
+60.64%
+60.64%
1 Month
+48.04%
+48.04%
3 Month
+48.04%
+48.04%
6 Month
+25.83%
+25.83%
1 Year
-62.25%
-62.25%

More News

Read More
PAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update Tomorrow
Tags PAOG Small Business OTC Stocks
From OTC
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Tags Corporate Small Caps CANNABIS
From OTC
PURA and ALKM To Reveal New Hemp Derived CBD Infused Product Lines Thursday December 10th
From PR Newswire
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2020
Tags COVID/19 Biotechnology Healthcare
From OTC
PAOG Confirms Q4 2020 Revenue From Cannabis Asset Acquisition
Tags CBD PRESS RELEASE COPD
From OTC
PURA and ALKM Move Forward On New Hemp Derived CBD Infused Product Production
From PR Newswire
PAOG Expects To Report First Post Acquisition Revenue In Q4 2020
Tags Biotechnology Healthcare Shareholders
From OTC
PAOG Develops CBD Nutraceutical For $12.7 Billion Market From Patented Extract Process
Tags PURA OTC Market Small Caps
From OTC
PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
Tags Healthcare COVID/19 biopharmaceutical
From OTC
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.